TRAF1 and Miyoshi myopathy: The stability of TRAF1 mRNA is then enhanced by YTHDF2 in an m6A-mediated manner, resulting in the activation of NF-κB and MAPK signaling pathways to accelerate MM cell growth and survival (78).